Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
- 1 December 2012
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 380 (9857), 1909-1915
- https://doi.org/10.1016/s0140-6736(12)61084-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Infliximab in severe ulcerative colitis: short‐term results of different infusion regimens and long‐term follow‐upAlimentary Pharmacology & Therapeutics, 2007
- Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006Alimentary Pharmacology & Therapeutics, 2007
- Low Colectomy Rates in Ulcerative Colitis in an Unselected European Cohort Followed for 10 YearsGastroenterology, 2007
- The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsGut, 2006
- Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitisGut, 2006
- Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid TherapyNew England Journal of Medicine, 1994
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- The course and prognosis of ulcerative colitis: Part I Short-term prognosisGut, 1963
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Cortisone in Ulcerative ColitisBMJ, 1955